Home LiteratureArticle Details
PMID: 21307168 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

β-catenin tyrosine 654 phosphorylation increases Wnt signalling and intestinal tumorigenesis.

Gut ·Vol. 60 ·No. 9 ·2011-09-00 ·Pages 1204-12

van Veelen W, Le NH, Helvensteijn W, Blonden L, Theeuwes M, Bakker ER, Franken PF, van Gurp L, Meijlink F, van der Valk MA, Kuipers EJ, Fodde R, Smits R

Abstract

Objective Deregulation of the Wnt signalling pathway by mutations in the Apc or β-catenin genes underlies colorectal carcinogenesis. As a result, β-catenin stabilises, translocates to the nucleus, and activates gene transcription. Intestinal tumours show a heterogeneous pattern of nuclear β-catenin, with the highest levels observed at the invasion front. Activation of receptor tyrosine kinases in these tumour areas by growth factors expressed by surrounding stromal cells phosphorylate β-catenin at tyrosine residues, which is thought to increase β-catenin nuclear translocation and tumour invasiveness. This study investigates the relevance of β-catenin tyrosine phosphorylation for Wnt signalling and intestinal tumorigenesis in vivo. Design A conditional knock-in mouse model was generated into which the phospho-mimicking Y654E modification in the endogenous β-catenin gene was introduced. Results This study provided in vivo evidence that β-catenin(E654) is characterised by reduced affinity for cadherins, increased signalling and strongly increased phosphorylation at serine 675 by protein kinase A (PKA). In addition, homozygosity for the β-catenin(E654) targeted allele caused embryonic lethality, whereas heterozygosity predisposed to intestinal tumour development, and strongly enhanced Apc-driven intestinal tumour initiation associated with increased nuclear accumulation of βcatenin. Surprisingly, the expression of β-catenin(E654) did not affect histological grade or induce tumour invasiveness. Conclusions A thus far unknown mechanism was uncovered in which Y654 phosphorylation of β-catenin facilitates additional phosphorylation at serine 675 by PKA. In addition, in contrast to the current belief that β-catenin Y654 phosphorylation increases tumour progression to a more invasive phenotype, these results show that it rather increases tumour initiation by enhancing Wnt signalling.

MeSH Terms
Adenoma/genetics,metabolism Animals COS Cells Cadherins/metabolism Cell Membrane/metabolism Cell Transformation, Neoplastic/genetics,metabolism Chlorocebus aethiops Colorectal Neoplasms/genetics,metabolism Cyclic AMP-Dependent Protein Kinases/pharmacology Embryo Loss/genetics Gene Knock-In Techniques Genes, APC Genotype Heterozygote Homozygote Mice Mice, Inbred C57BL Phosphorylation/drug effects,physiology Wnt Proteins/physiology beta Catenin/metabolism
Chemicals
Cadherins Wnt Proteins beta Catenin Cyclic AMP-Dependent Protein Kinases
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
van Veelen Wendy
Department of Gastroenterology and Hepatology, Erasmus MC-University Medical Centre, room L-63, 's Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. w.vanveelen@erasmusmc.nl
Le Ngoc H
Helvensteijn Werner
Blonden Lau
Theeuwes Myrte
Bakker Elvira R M
Franken Patrick F
van Gurp Léon
Meijlink Frits
van der Valk Martin A
Kuipers Ernst J
Fodde Riccardo
Smits Ron
References (37)
37 references, click to expand
  1. The discovery of receptor tyrosine kinases: targets for cancer therapy.
    Nat Rev Cancer. 2004 May;4(5):361-70 PMID: 15122207
  2. Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway.
    Am J Pathol. 1999 Feb;154(2):515-23 PMID: 10027409
  3. The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin.
    Curr Opin Cell Biol. 2005 Oct;17(5):459-65 PMID: 16099633
  4. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase stabilizes beta-catenin through inhibition of its ubiquitination.
    Mol Cell Biol. 2005 Oct;25(20):9063-72 PMID: 16199882
  5. Phosphorylation of beta-catenin by cyclic AMP-dependent protein kinase.
    J Biol Chem. 2006 Apr 14;281(15):9971-6 PMID: 16476742
  6. Colorectal cancer in review: the role of the EGFR pathway.
    Expert Opin Investig Drugs. 2010 Mar;19(3):357-69 PMID: 20095919
  7. Crystal structure of a full-length beta-catenin.
    Structure. 2008 Mar;16(3):478-87 PMID: 18334222
  8. APC, signal transduction and genetic instability in colorectal cancer.
    Nat Rev Cancer. 2001 Oct;1(1):55-67 PMID: 11900252
  9. Nuclear overexpression of the oncoprotein beta-catenin in colorectal cancer is localized predominantly at the invasion front.
    Pathol Res Pract. 1998;194(10):701-4 PMID: 9820866
  10. Regulation of beta-catenin structure and activity by tyrosine phosphorylation.
    J Biol Chem. 2001 Jun 8;276(23):20436-43 PMID: 11279024
  11. Balancing cell adhesion and Wnt signaling, the key role of beta-catenin.
    Curr Opin Genet Dev. 2006 Feb;16(1):51-9 PMID: 16377174
  12. Regulation of E-cadherin/Catenin association by tyrosine phosphorylation.
    J Biol Chem. 1999 Dec 17;274(51):36734-40 PMID: 10593980
  13. Cytoskeletal reorganization by soluble Wnt-3a protein signalling.
    Genes Cells. 1998 Oct;3(10):659-70 PMID: 9893023
  14. Tumorigenesis in the multiple intestinal neoplasia mouse: redundancy of negative regulators and specificity of modifiers.
    Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3461-6 PMID: 10716720
  15. ErbB receptors and signaling pathways in cancer.
    Curr Opin Cell Biol. 2009 Apr;21(2):177-84 PMID: 19208461
  16. A transgenic mouse line that retains Cre recombinase activity in mature oocytes irrespective of the cre transgene transmission.
    Biochem Biophys Res Commun. 1997 Aug 18;237(2):318-24 PMID: 9268708
  17. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas.
    Am J Pathol. 2000 Mar;156(3):865-70 PMID: 10702403
  18. Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer.
    FEBS J. 2010 Jan;277(2):301-8 PMID: 19922469
  19. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
    PLoS Genet. 2009 Jul;5(7):e1000547 PMID: 19578404
  20. Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration.
    Cell. 2009 Mar 20;136(6):1136-47 PMID: 19303855
  21. Defining the function of beta-catenin tyrosine phosphorylation in cadherin-mediated cell-cell adhesion.
    Genes Cells. 2008 Jan;13(1):67-77 PMID: 18173748
  22. Dickkopf1 is required for embryonic head induction and limb morphogenesis in the mouse.
    Dev Cell. 2001 Sep;1(3):423-34 PMID: 11702953
  23. Genetic dissection of differential signaling threshold requirements for the Wnt/beta-catenin pathway in vivo.
    PLoS Genet. 2010 Jan 15;6(1):e1000816 PMID: 20084116
  24. A new conditional Apc-mutant mouse model for colorectal cancer.
    Carcinogenesis. 2010 May;31(5):946-52 PMID: 20176656
  25. Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and beta-catenin.
    Cells Tissues Organs. 2005;179(1-2):56-65 PMID: 15942193
  26. Requirement for tumor suppressor Apc in the morphogenesis of anterior and ventral mouse embryo.
    Dev Biol. 2003 Jan 15;253(2):230-46 PMID: 12645927
  27. Apc1638T: a mouse model delineating critical domains of the adenomatous polyposis coli protein involved in tumorigenesis and development.
    Genes Dev. 1999 May 15;13(10):1309-21 PMID: 10346819
  28. Molecular genetics of multiple endocrine neoplasia types 1 and 2.
    Nat Rev Cancer. 2005 May;5(5):367-75 PMID: 15864278
  29. Phosphorylation of beta-catenin by PKA promotes ATP-induced proliferation of vascular smooth muscle cells.
    Am J Physiol Cell Physiol. 2008 May;294(5):C1169-74 PMID: 18353896
  30. Apc1638N: a mouse model for familial adenomatous polyposis-associated desmoid tumors and cutaneous cysts.
    Gastroenterology. 1998 Feb;114(2):275-83 PMID: 9453487
  31. Inducible gene knockouts in the small intestinal and colonic epithelium.
    J Biol Chem. 1999 Dec 31;274(53):38071-82 PMID: 10608876
  32. Dapper, a Dishevelled-associated antagonist of beta-catenin and JNK signaling, is required for notochord formation.
    Dev Cell. 2002 Apr;2(4):449-61 PMID: 11970895
  33. A targeted chain-termination mutation in the mouse Apc gene results in multiple intestinal tumors.
    Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):8969-73 PMID: 8090754
  34. Wnt/beta-catenin signaling in cancer stemness and malignant behavior.
    Curr Opin Cell Biol. 2007 Apr;19(2):150-8 PMID: 17306971
  35. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
    Cancer Res. 2001 Feb 15;61(4):1671-7 PMID: 11245482
  36. Pathology of mouse models of intestinal cancer: consensus report and recommendations.
    Gastroenterology. 2003 Mar;124(3):762-77 PMID: 12612914
  37. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias.
    Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):8977-81 PMID: 8415640
Article Info
Journal
Gut
Abbr.
Gut
ISSN
1468-3288
Published
2011-09-00
Epub
2011-00-09
Pages
1204-12
Language
English
Region
England
NLM ID
2985108R
PMCID
PMC3152867
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com